These epigenetically silenced genes include epithelial-associated cell adhesion molecule, E-cadherin, and glycolytic antagonist, fructose-1,6-biphosphatase (FBP1), which contribute to EMT development and the switch to glycolytic metabolism in breast cancer cells (37). Here, FBP1 is linked to breast carcinoma.